These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6800678)

  • 21. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of concurrent administration of metoprolol and tocainide in acute myocardial infarction.
    Renard MB; Bernard RM; Ewalenko MB; Englert M
    J Cardiovasc Pharmacol; 1983; 5(1):116-20. PubMed ID: 6186845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 24. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
    Kwok DW; McErlane KM; Axelson JE
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats.
    Capucci A; Frabetti L; Gubelli S; Boriani G; Marchesini B; Boschi S; Ambrosioni E; Magnani B
    Clin Cardiol; 1989 Jun; 12(6):322-31. PubMed ID: 2472242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy. Tocainide.
    Roden DM; Woosley RL
    N Engl J Med; 1986 Jul; 315(1):41-5. PubMed ID: 3086724
    [No Abstract]   [Full Text] [Related]  

  • 27. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tocainide on Purkinje fibers from normal and infarcted ventricular tissues.
    Dersham GH; Han J; Cameron JS; O'Connell DP
    J Electrocardiol; 1986 Oct; 19(4):355-9. PubMed ID: 3098883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.
    Todt H; Zojer N; Raberger G
    Br J Pharmacol; 1993 Sep; 110(1):145-50. PubMed ID: 8220875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M
    Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract]   [Full Text] [Related]  

  • 33. Disposition of (R,S)-tocainide. Some stereoselective aspects.
    Gal J; French TA; Zysset T; Haroldsen PE
    Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles.
    Man RY; Dresel PE
    J Cardiovasc Pharmacol; 1979; 1(3):329-42. PubMed ID: 94400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tocainide kinetics in congestive heart failure.
    Mohiuddin SM; Esterbrooks D; Hilleman DE; Aronow WS; Patterson AJ; Sketch MH; Mooss AN; Hee TT; Reich JW
    Clin Pharmacol Ther; 1983 Nov; 34(5):596-603. PubMed ID: 6414753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI; Alpert JS; Dalen JE
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart.
    Duker BG
    Cardiovasc Res; 1991 Mar; 25(3):217-22. PubMed ID: 1903081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic effects of tocainide and lidocaine in dogs.
    Aberg G; Ronfeld R; Aberg L; Fitzgerald T; McCollom K; Moller R
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):146-52. PubMed ID: 6414246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.